Novanta Inc (NASDAQ:NOVT) CEO Matthijs Glastra sold 12,633 shares of the stock in a transaction on Monday, January 13th. The stock was sold at an average price of $95.02, for a total transaction of $1,200,387.66. Following the transaction, the chief executive officer now directly owns 119,644 shares in the company, valued at $11,368,572.88. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Matthijs Glastra also recently made the following trade(s):

  • On Thursday, January 2nd, Matthijs Glastra sold 8,000 shares of Novanta stock. The stock was sold at an average price of $89.53, for a total transaction of $716,240.00.

Shares of NASDAQ:NOVT opened at $94.66 on Thursday. The company has a market cap of $3.33 billion, a P/E ratio of 43.82 and a beta of 1.47. The stock’s 50-day moving average is $90.79 and its 200-day moving average is $84.67. Novanta Inc has a 52-week low of $64.99 and a 52-week high of $96.44. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.43 and a current ratio of 2.38.

Novanta (NASDAQ:NOVT) last issued its quarterly earnings results on Tuesday, November 5th. The technology company reported $0.53 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.52 by $0.01. The company had revenue of $154.10 million for the quarter, compared to the consensus estimate of $155.04 million. Novanta had a return on equity of 20.01% and a net margin of 6.94%. The firm’s revenue was down 4.2% compared to the same quarter last year. During the same period last year, the business posted $0.61 earnings per share. As a group, equities analysts predict that Novanta Inc will post 2.14 EPS for the current year.

Several research firms have commented on NOVT. BidaskClub downgraded shares of Novanta from a “buy” rating to a “hold” rating in a research report on Friday, December 27th. Zacks Investment Research raised shares of Novanta from a “sell” rating to a “hold” rating in a research report on Wednesday, October 9th.

Several large investors have recently modified their holdings of NOVT. JPMorgan Chase & Co. grew its position in shares of Novanta by 19.7% in the second quarter. JPMorgan Chase & Co. now owns 11,312 shares of the technology company’s stock valued at $1,055,000 after purchasing an additional 1,864 shares during the last quarter. Bank of Montreal Can acquired a new stake in shares of Novanta in the second quarter valued at about $265,000. Charles Schwab Investment Management Inc. grew its position in shares of Novanta by 2.9% in the second quarter. Charles Schwab Investment Management Inc. now owns 193,139 shares of the technology company’s stock valued at $18,214,000 after purchasing an additional 5,476 shares during the last quarter. Northern Trust Corp grew its position in shares of Novanta by 0.4% in the second quarter. Northern Trust Corp now owns 456,213 shares of the technology company’s stock valued at $43,021,000 after purchasing an additional 1,971 shares during the last quarter. Finally, BlackRock Inc. grew its position in shares of Novanta by 2.9% in the second quarter. BlackRock Inc. now owns 2,272,456 shares of the technology company’s stock valued at $214,293,000 after purchasing an additional 64,655 shares during the last quarter. 88.83% of the stock is currently owned by institutional investors.

Novanta Company Profile

Novanta Inc, together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. The company's Photonics segment offers photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products for photonics-based applications, such as industrial material processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures.

Further Reading: FinTech

Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.